May cause drowsiness — Label Decoder

Official label information

Neurontin labeling warns that gabapentin causes somnolence, sedation, and dizziness, and that CNS depression can be greater with other sedative drugs. Patients are advised not to drive or operate complex machinery until they know how the medicine affects them.

Plain-language explanation

This warns that sleepiness, slowed reactions, or feeling less alert can occur. The effect may be more noticeable when treatment changes or when other sedating substances are involved.

What this often means for gabapentin products

In adult postherpetic neuralgia trials summarized in that label, somnolence occurred in 21% of Neurontin-treated patients versus 5% with placebo. Sleepiness is a labeled effect, not proof that the drug is “working.” Combining gabapentin with alcohol, opioids, or sleep medicines can intensify sedation and breathing risk.

Ask your pharmacist

Ask what signs of excessive sleepiness should prompt a call to the pharmacy or clinician.

Caution: Do not drive or do hazardous work until a clinician or pharmacist has advised you about your own situation.

Sources

DailyMed: NEURONTIN (gabapentin) capsules, tablets, and oral solution — U.S. National Library of Medicine
FDA Drug Safety Communication: serious breathing problems with gabapentin and pregabalin — U.S. Food and Drug Administration
MedlinePlus: Gabapentin — MedlinePlus / National Library of Medicine

This decoder does not diagnose, set a personal dose, or create a taper schedule. If two instructions conflict, pause and ask the dispensing pharmacist.